1	Fludarabine-induced	fludarabine-induced	_	_	_	_	_	_	_
2	immunosuppression	immunosuppression	_	_	_	_	_	_	_
3	is	be	_	_	_	_	_	_	_
4	associated	associate	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	inhibition	inhibition	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	STAT1	stat1	_	_	_	_	_	_	_
9	signaling	signaling	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	Fludarabine	Fludarabine	_	_	_	_	_	_	_
2	is	be	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	nucleoside	nucleoside	_	_	_	_	_	_	_
5	analog	analog	_	_	_	_	_	_	_
6	used	use	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	treatment	treatment	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	hematologic	hematologic	_	_	_	_	_	_	_
12	malignancies	malignancy	_	_	_	_	_	_	_
13	that	that	_	_	_	_	_	_	_
14	can	can	_	_	_	_	_	_	_
15	induce	induce	_	_	_	_	_	_	_
16	severe	severe	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	prolonged	prolonged	_	_	_	_	_	_	_
19	immunosuppression	immunosuppression	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Although	although	_	_	_	_	_	_	_
2	it	it	_	_	_	_	_	_	_
3	can	can	_	_	_	_	_	_	_
4	be	be	_	_	_	_	_	_	_
5	incorporated	incorporate	_	_	_	_	_	_	_
6	into	into	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	DNA	dna	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	dividing	divide	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	fludarabine	fludarabine	_	_	_	_	_	_	_
14	is	be	_	_	_	_	_	_	_
15	also	also	_	_	_	_	_	_	_
16	a	a	_	_	_	_	_	_	_
17	potent	potent	_	_	_	_	_	_	_
18	inhibitor	inhibitor	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	cells	cell	_	_	_	_	_	_	_
21	with	with	_	_	_	_	_	_	_
22	a	a	_	_	_	_	_	_	_
23	low	low	_	_	_	_	_	_	_
24	growth	growth	_	_	_	_	_	_	_
25	fraction	fraction	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	thus	thus	_	_	_	_	_	_	_
28	it	it	_	_	_	_	_	_	_
29	must	must	_	_	_	_	_	_	_
30	have	have	_	_	_	_	_	_	_
31	other	other	_	_	_	_	_	_	_
32	mechanisms	mechanism	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	action	action	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	STAT1	STAT1	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	which	which	_	_	_	_	_	_	_
4	is	be	_	_	_	_	_	_	_
5	activated	activate	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	response	response	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	many	many	_	_	_	_	_	_	_
10	lymphocyte-activating	lymphocyte-activating	_	_	_	_	_	_	_
11	cytokines	cytokine	_	_	_	_	_	_	_
12	including	include	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	interferons	interferon	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	is	be	_	_	_	_	_	_	_
17	essential	essential	_	_	_	_	_	_	_
18	for	for	_	_	_	_	_	_	_
19	cell-mediated	cell-mediated	_	_	_	_	_	_	_
20	immunity	immunity	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	as	as	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	absence	absence	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	this	this	_	_	_	_	_	_	_
27	protein	protein	_	_	_	_	_	_	_
28	is	be	_	_	_	_	_	_	_
29	associated	associate	_	_	_	_	_	_	_
30	with	with	_	_	_	_	_	_	_
31	prominent	prominent	_	_	_	_	_	_	_
32	defects	defect	_	_	_	_	_	_	_
33	in	in	_	_	_	_	_	_	_
34	the	the	_	_	_	_	_	_	_
35	ability	ability	_	_	_	_	_	_	_
36	to	to	_	_	_	_	_	_	_
37	control	control	_	_	_	_	_	_	_
38	viral	viral	_	_	_	_	_	_	_
39	infections	infection	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	Here	here	_	_	_	_	_	_	_
2	we	we	_	_	_	_	_	_	_
3	show	show	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	fludarabine	fludarabine	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	but	but	_	_	_	_	_	_	_
8	not	not	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	immunosuppressant	immunosuppressant	_	_	_	_	_	_	_
11	cyclosporine	cyclosporine	_	_	_	_	_	_	_
12	A	A	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	inhibits	inhibit	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	cytokine-induced	cytokine-induced	_	_	_	_	_	_	_
17	activation	activation	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	STAT1	STAT1	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	STAT1-dependent	stat1-dependent	_	_	_	_	_	_	_
22	gene	gene	_	_	_	_	_	_	_
23	transcription	transcription	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	normal	normal	_	_	_	_	_	_	_
26	resting	rest	_	_	_	_	_	_	_
27	or	or	_	_	_	_	_	_	_
28	activated	activate	_	_	_	_	_	_	_
29	lymphocytes	lymphocyte	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	Fludarabine	Fludarabine	_	_	_	_	_	_	_
2	caused	cause	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	specific	specific	_	_	_	_	_	_	_
5	depletion	depletion	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	STAT1	stat1	_	_	_	_	_	_	_
8	protein	protein	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	mRNA	mrna	_	_	_	_	_	_	_
12	)	)	_	_	_	_	_	_	_
13	but	but	_	_	_	_	_	_	_
14	not	not	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	other	other	_	_	_	_	_	_	_
17	STATs	stat	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	loss	loss	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	STAT1	STAT1	_	_	_	_	_	_	_
5	was	be	_	_	_	_	_	_	_
6	also	also	_	_	_	_	_	_	_
7	seen	see	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	from	from	_	_	_	_	_	_	_
11	patients	patient	_	_	_	_	_	_	_
12	treated	treat	_	_	_	_	_	_	_
13	with	with	_	_	_	_	_	_	_
14	fludarabine	fludarabine	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	vivo	vivo	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	Brief	brief	_	_	_	_	_	_	_
2	exposure	exposure	_	_	_	_	_	_	_
3	to	to	_	_	_	_	_	_	_
4	fludarabine	fludarabine	_	_	_	_	_	_	_
5	led	lead	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	sustained	sustained	_	_	_	_	_	_	_
9	loss	loss	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	STAT1	STAT1	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	analogous	analogous	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	prolonged	prolonged	_	_	_	_	_	_	_
17	period	period	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	immunosuppression	immunosuppression	_	_	_	_	_	_	_
20	induced	induce	_	_	_	_	_	_	_
21	by	by	_	_	_	_	_	_	_
22	exposure	exposure	_	_	_	_	_	_	_
23	to	to	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	drug	drug	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	vivo	vivo	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Thus	thus	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	STAT1	STAT1	_	_	_	_	_	_	_
4	may	may	_	_	_	_	_	_	_
5	be	be	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	useful	useful	_	_	_	_	_	_	_
8	target	target	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	development	development	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	new	new	_	_	_	_	_	_	_
14	immunosuppressive	immunosuppressive	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	antineoplastic	antineoplastic	_	_	_	_	_	_	_
17	agents	agent	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

